OrbiMed’s AstraZeneca AZN Stock Holding History

OrbiMed’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$132M	Buy	+670,200	New	+$129M	2.88%	9
2025 Q4	–	Hold	0	–	–	–	115
2025 Q3	–	Hold	0	–	–	–	113
2025 Q2	–	Hold	0	–	–	–	104
2023 Q4	–	Hold	0	–	–	–	117
2023 Q3	–	Hold	0	–	–	–	129
2021 Q4	–	Hold	0	–	–	–	160
2021 Q3	–	Hold	0	–	–	–	177
2020 Q1	–	Sell	-34,800	Closed	-$3.47M	–	147
2019 Q4	$3.47M	Buy	+34,800	New	+$3.28M	0.05%	110
2017 Q3	–	Hold	0	–	–	–	145
2017 Q2	–	Hold	0	–	–	–	140
2014 Q2	–	Hold	0	–	–	–	136
2014 Q1	–	Hold	0	–	–	–	143

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $117B AUM